Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Zhaotao Wang"'
Autor:
Ji Wang, Shiquan Shen, Jian You, Zhaotao Wang, Yan Li, Yanming Chen, Yonghua Tuo, Danmin Chen, Haoming Yu, Jingbo Zhang, Fangran Wang, Xiao Pang, Zongyu Xiao, Qing Lan, Yezhong Wang
Publikováno v:
Cell Death and Disease, Vol 15, Iss 7, Pp 1-13 (2024)
Abstract Invasion and migration are the key hallmarks of cancer, and aggressive growth is a major factor contributing to treatment failure and poor prognosis in glioblastoma. Protein arginine methyltransferase 6 (PRMT6), as an epigenetic regulator, h
Externí odkaz:
https://doaj.org/article/94d993e7d01f479fb3405fccedb7cb20
Autor:
Yuheng Xu, Wanqi Weng, Yuhao Weng, Danmin Chen, Ziwen Zheng, Zexian Fan, Chengxiang Peng, Yuanyi Xiong, Xiao Pang, Guobin Cao, Yezhong Wang, Quan Mo, Zhaotao Wang, Shizhen Zhang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-21 (2024)
Abstract The role of SLC3A2, a gene implicated in disulfidptosis, has not been characterized in gliomas. This study aims to clarify the prognostic value of SLC3A2 and its influence on glioma. We evaluated the expression of SLC3A2 and its prognostic i
Externí odkaz:
https://doaj.org/article/6c13f6143a7f442e8f32c4530817e830
Autor:
Renheng Zou, Xunlong Zhong, Kairong Liang, Cheng Zhi, Danmin Chen, Zhichao Xu, Jingbai Zhang, Degui Liao, Miaoling Lai, Yuhao Weng, Huaidong Peng, Xiao Pang, Yunxiang Ji, Yanbin Ke, Hongri Zhang, Zhaotao Wang, Yezhong Wang
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-21 (2023)
Abstract Background Leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1) is regarded as an inhibitory molecule. However, the importance of LILRB1 expression in glioma has not yet been determined. This investigation examined the immunological
Externí odkaz:
https://doaj.org/article/43de08c7718240fba7a921c32173ca76
Autor:
Jiajie Lu, Yuecheng Peng, Rihong Huang, Zejia Feng, Yongyang Fan, Haojian Wang, Zhaorong Zeng, Yunxiang Ji, Yezhong Wang, Zhaotao Wang
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Tyrosine protein tyrosine kinase binding protein (TYROBP) binds non-covalently to activated receptors on the surface of various immune cells, and mediates signal transduction and cellular activation. It is dysregulated in various
Externí odkaz:
https://doaj.org/article/5c4a29710d9646529c31722d4e2d5ee8
Autor:
Zhi Liu, Zhaotao Wang, Danmin Chen, Xiaorui Liu, Guoyong Yu, Yan Zhang, Chen Chen, Ruxiang Xu, Yezhong Wang, Ru-en Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Epithelial-to-mesenchymal transition (EMT) and angiogenesis have emerged as two pivotal events in cancer progression. Paeoniflorin has been widely studied in experimental models and clinical trials for cancer treatment because of its anti-cancer prop
Externí odkaz:
https://doaj.org/article/b421e233c6bf4ad58f012bf441ac5fcd
Autor:
Zhaotao Wang, Rihong Huang, Haojian Wang, Yuecheng Peng, Yongyang Fan, Zejia Feng, Zhaorong Zeng, Yunxiang Ji, Yezhong Wang, Jiajie Lu
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Despite emerging evidence revealing the remarkable roles of protein phosphatase 1 regulatory inhibitor subunit 14A (PPP1R14A) in cancer tumorigenesis and progression, no pan-cancer analysis is available. A comprehensive investigation of the potential
Externí odkaz:
https://doaj.org/article/3b83907c2838476fbf92b31065c5bd47
Autor:
Zhaotao, Wang, Yongping, Li, Minyi, Liu, Danmin, Chen, Jiajie, Lu, Yunxiang, Ji, Zhou, Xing, Yezhong, Wang
Publikováno v:
Journal of Cancer. 13:1203-1213
Autor:
Yubiao Yue, Zhenzhang Li, Shizhen Zhang, Zhaotao Wang, Xinyue Zhang, Shaoan Zhang, S. Saravanakumar, Jialong Xu, Weiren Zhao, Jinbao Liu, Yang Li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8521aea959cecccae2d348b4efa2e057
https://doi.org/10.2139/ssrn.4389613
https://doi.org/10.2139/ssrn.4389613
Autor:
Ji Wang, Zongyu Xiao, Peng Li, Chunwang Wu, Yan Li, Qing Wang, Yanming Chen, Honglong Zhou, Zhi Li, Zhaotao Wang, Qing Lan, Yezhong Wang
PRMT6, a type I arginine methyltransferase, di-methylates the arginine residues of both histones and non-histones asymmetrically. Increasing evidence indicates that PRMT6 plays a tumor mediator involved in human malignancies. Here, we aim to uncover
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22fdeebae5aa15d7e15458f0915e146
https://doi.org/10.21203/rs.3.rs-2167026/v1
https://doi.org/10.21203/rs.3.rs-2167026/v1
Autor:
Yanmei Zhong, Yingying Xu, Yongzhen Tan, Xuanxuan Zhang, Ruolun Wang, Danmin Chen, Zhaotao Wang, Xunlong Zhong
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 230:115386